Visual Assessment Versus Quantitative Three-Dimensional Stereotactic Surface Projection Fluorodeoxyglucose Positron Emission Tomography for Detection of Mild Cognitive Impairment and Alzheimer Disease
Clinical Nuclear Medicine , 07/16/2012
Lehman VT et al. – The use of commercially available 3–dimensional stereotactic surface projection (3D–SSP) quantitation improved diagnostic accuracy for evaluation of mild cognitive impairment (MCI) and Alzheimer disease (AD) with 18F FDG PET.



